BELE LIFEPAR Stock

BLAC

US0791741087

Market Closed - Nasdaq 23:58:25 04/09/2026 +04			5-day change	1st Jan Change
0.2250 ^USD	-8.14%		-13.46%	-92.52%

18/02/25	Bellevue Life Sciences Acquisition Corp. will Change its Name to OSR Holdings, Inc	CI
18/02/25	Bellevue Life Sciences Acquisition Corp. will Change its Ticker to OSRH from BLAC	CI

OSR Holdings, Inc. is a global healthcare company, dedicated to advancing healthcare outcomes and improving the quality of life for people and their families. The Company is focused on building and developing a portfolio of transformative therapies and healthcare solutions. The Company's operating businesses (through its three wholly owned subsidiaries) include developing oral immunotherapies for the treatment of cancer, developing design-augmented biologics for age-related and other degenerative diseases and neurovascular intervention medical device and systems distribution in Korea. The Company has business operations in the United States, Europe and South Korea.

Employees

Sector

More about the company

Quotes

Date	Price	Change
04/09/26	$0.2250	-8.14%
03/09/26	$0.2450	-24.63%
02/09/26	$0.3250	-3.70%
01/09/26	$0.3375	+22.73%
31/08/26	$0.2750	+5.77%

Delayed Quote Nasdaq

More quotes

Market Cap	46.6M 40.1M 37.72M 34.46M 64.47M 4.4B 64.64M 446M 173M 2.26B 175M 171M 7.27B	P/E 2022 *	-	P/E 2023	210x
Enterprise Value	46.65M 40.14M 37.77M 34.5M 64.54M 4.4B 64.72M 446M 173M 2.26B 175M 171M 7.28B	EV / Sales 2022 *	-	EV / Sales 2023	-
Free-Float	-	Yield 2022 *	-	Yield 2023	-

18/02/25	Bellevue Life Sciences Acquisition Corp. will Change its Name to OSR Holdings, Inc	CI
18/02/25	Bellevue Life Sciences Acquisition Corp. will Change its Ticker to OSRH from BLAC	CI
17/02/25	Bellevue Life Sciences Acquisition Corp.(NasdaqCM:BLAC) dropped from NASDAQ Composite Index	CI
14/02/25	Top Midday Decliners	MT
14/02/25	Wall Street Set to Open Slightly Lower Friday as Retail Sales Slump More Than Expected	MT
14/02/25	Top Premarket Decliners	MT
14/02/25	US Futures Modestly Lower as Investors Await Retail Sales, Industrial Production Data	MT
14/02/25	OSR Holdings.Co.,Ltd. completed the acquisition of Bellevue Life Sciences Acquisition Corp. from Bellevue Global Life Sciences Investors, LLC, BCM Europe AG, RiverNorth Capital Management, LLC and others for in a reverse merger transaction.	CI
10/02/25	Top Premarket Decliners	MT
24/01/25	Bellevue Life Sciences Acquisition Corp. and Sponsor Enter into A Second Amendment to Amend the Maturity Date of Each Promissory Note	CI
11/01/25	Bellevue Life Sciences Acquisition Corp. and Bellevue Global Life Sciences Investors Enters into an Amendment to Extend the Maturity Date of Each Promissory Note	CI
15/11/24	Bellevue Life Sciences Acquisition Corp. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2024	CI
16/10/24	Bellevue Life Sciences Acquisition Corp. announced that it has received $0.8 million in funding	CI

04/04/25	$2 Stocks to Watch: PNPN.V, TIVC, APVO, OSRH, PRSO Biotech Breakthroughs, MedTech Momentum Metallic Metals Power Play & Signal Innovation	AQ
27/03/25	Driving the Future of Healthcare HIT, OSRH, THTX, LPTX, CSDX, Innovations in Health Insurance, Virtual Care, Oncology, and Chronic Disease Treatment	AQ
17/02/25	OSR Holdings, Inc. and OSR Holdings Co., Ltd. Announce Completion of Business Combination	AQ
15/02/25	OSR Holdings, Inc. and OSR Holdings Co., Ltd. Announce Completion of Business Combination	PR
14/02/25	Bellevue Life Sciences Acquisition Corp. Announces Approval of Business Combination Proposal And Name Change to OSR Holdings, Inc.	PR

	2022	2023
Net sales	-	-
Net income	-35.39K -30.45K -28.65K -26.17K -48.96K -3.34M -49.09K -339K -131K -1.71M -133K -130K -5.52M	404K 347K 327K 299K 559K 38.12M 560K 3.86M 1.5M 19.56M 1.52M 1.48M 63.01M
Net Debt	1.09M 940K 884K 808K 1.51M 103M 1.52M 10.45M 4.06M 52.92M 4.1M 4.01M 170M	56.58K 48.69K 45.81K 41.85K 78.28K 5.34M 78.49K 541K 210K 2.74M 212K 208K 8.83M

BELE LIFEPAR Stock

Stocks

BLAC

US0791741087

Valuation : BELE LIFEPAR

Chart: BELE LIFEPAR

Latest news : BELE LIFEPAR

Press Releases : BELE LIFEPAR

Quotes and Performance

Price Extremes

Financials

Company Profile

Quotes

1 day	-8.14%
Current month	-92.52%
Current year	-92.52%

3 years	0.2	13.4
5 years	0.2	13.4
10 years	0.2	13.4